Home > Boards > US Listed > Biotechs > Acadia Pharmaceuticals Inc. (ACAD)

Good News!!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gi197845 Member Profile
 
Followed By 4
Posts 2,659
Boards Moderated 1
Alias Born 08/16/16
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2021 5:34:13 PM
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire - 9/2/2021 9:00:00 AM
Acadia Pharmaceuticals Announces Executive Leadership Change Business Wire - 9/1/2021 4:05:00 PM
Dermata therapeutics appoints Kyri Van Hoose as CFO Seeking Alpha - 9/1/2021 6:55:32 AM
Acadia Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021 Business Wire - 8/5/2021 4:05:00 PM
DRP Treatment’s Path Ahead Unclear, yet Current Risk/Reward Appears Favorable TipRanks - 8/5/2021 10:55:30 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 6:03:49 AM
ACADIA Pharma slides after 2021 guidance lagged expectations Seeking Alpha - 8/4/2021 5:03:42 PM
ACADIA Pharma EPS beats by $0.03, misses on revenue; FY21 guidance lowered Seeking Alpha - 8/4/2021 4:22:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2021 4:17:05 PM
Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results Business Wire - 8/4/2021 4:05:00 PM
The Street’s Gaze Turns to FDA Meeting’s Outcome on DRP Treatment TipRanks - 8/3/2021 7:30:30 PM
The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis Business Wire - 7/21/2021 5:05:00 PM
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer’s Asso... Business Wire - 7/14/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2021 5:02:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:43:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:42:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:41:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:40:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:39:45 PM
NUPLAZID® (pimavanserin) Efficacy Data from Open-Label Extension (OLE) Study Published in Parkinsonism and Related Disorders Business Wire - 6/3/2021 11:26:00 AM
NUPLAZID® (pimavanserin) Efficacy Data from Open-Label Extension (OLE) Study Published in Parkinsonism and Related Disorders Business Wire - 6/3/2021 9:00:00 AM
Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 5/12/2021 4:22:37 PM
Acadia maintains 2021 sales guidance as Q1 net sales rise 18% Seeking Alpha - 5/5/2021 5:14:46 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 4:20:21 PM
gi197845   Monday, 09/13/21 10:00:38 PM
Re: None
Post # of 3045 
Good News!!!
I just applied for the new CFA position, with Acadia, to replace Elena Ridloff.
I'll right this titanic ship, straight away!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences